Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Abiomed Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in thousands

	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Accounts payable	35,346)	34,842)	32,774)	32,185)	23,565)	20,620)
Employee compensation	50,649)	40,954)	32,273)	32,926)	30,330)	23,290)
Research and development	7,337)	6,983)	5,749)	3,309)	3,162)	2,349)
Marketing	2,289)	3,674)	1,705)	1,707)	2,305)	1,827)
Warranty	1,935)	2,053)	1,818)	1,272)	1,081)	717)
Sales and income taxes	1,931)	5,914)	21,641)	12,262)	4,562)	3,180)
Professional, legal and accounting fees	1,479)	1,957)	6,880)	2,757)	1,870)	2,019)
Other	7,009)	4,511)	5,041)	3,187)	2,837)	4,321)
Accrued expenses	72,629)	66,046)	75,107)	57,420)	46,147)	37,703)
Deferred revenue	26,362)	24,322)	19,147)	16,393)	14,970)	10,495)
Other current liabilities	4,120)	3,759)	4,857)	—)	—)	—)
Current portion of capital lease obligation	—)	—)	—)	—)	—)	799)
Current liabilities	138,457)	128,969)	131,885)	105,998)	84,682)	69,617)
Other long-term liabilities	9,319)	10,162)	9,305)	1,061)	776)	3,251)
Contingent consideration	21,510)	24,706)	9,000)	9,575)	10,490)	9,153)
Deferred tax liabilities	781)	847)	806)	822)	903)	783)
Capital lease obligation, net of current portion	—)	—)	—)	—)	—)	15,539)
Long-term liabilities	31,610)	35,715)	19,111)	11,458)	12,169)	28,726)
Total liabilities	170,067)	164,684)	150,996)	117,456)	96,851)	98,343)
Class B Preferred Stock, $.01 par value; none issued and outstanding	—)	—)	—)	—)	—)	—)
Common stock, $.01 par value	455)	453)	451)	451)	444)	437)
Additional paid in capital	870,074)	800,690)	739,133)	690,507)	619,905)	565,962)
Retained earnings (accumulated deficit)	964,512)	828,007)	602,482)	399,473)	140,457)	(46,959)
Treasury stock at cost	(304,555)	(288,030)	(265,411)	(138,852)	(67,078)	(46,763)
Accumulated other comprehensive loss	(27,160)	(11,445)	(11,189)	(14,689)	(4,204)	(20,606)
Stockholders’ equity	1,503,326)	1,329,675)	1,065,466)	936,890)	689,524)	452,071)
Total liabilities and stockholders’ equity	1,673,393)	1,494,359)	1,216,462)	1,054,346)	786,375)	550,414)

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Download chart

Balance sheet item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Abiomed Inc. current liabilities decreased from 2020 to 2021 but then increased from 2021 to 2022 exceeding 2020 level.
Long-term liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	Abiomed Inc. long-term liabilities increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Abiomed Inc. total liabilities increased from 2020 to 2021 and from 2021 to 2022.
Stockholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	Abiomed Inc. stockholders’ equity increased from 2020 to 2021 and from 2021 to 2022.

Abiomed Inc. (NASDAQ:ABMD)

Balance Sheet: Liabilities and Stockholders’ Equity